Confluence Wealth Management’s Gilead Sciences GILD Stock Holding History

Confluence Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,142	Closed	-$320K	–	117
2018 Q3	$320K	Sell	4,142 -50	-1%	-$3.78K	0.17%	105
2018 Q2	$297K	Buy	+4,192	New	+$296K	0.16%	102
2017 Q1	–	Sell	-12,689	Closed	-$909K	–	133
2016 Q4	$909K	Sell	12,689 -3,958	-24%	-$294K	0.45%	56
2016 Q3	$1.32M	Sell	16,647 -465	-3%	-$37.8K	0.64%	38
2016 Q2	$1.43M	Sell	17,112 -2,406	-12%	-$214K	0.7%	32
2016 Q1	$1.79M	Sell	19,518 -369	-2%	-$33.3K	0.81%	30
2015 Q4	$2.01M	Sell	19,887 -677	-3%	-$70.4K	0.98%	22
2015 Q3	$2.02M	Buy	20,564 +106	+0.5%	+$11.8K	1.09%	19
2015 Q2	$2.4M	Sell	20,458 -291	-1%	-$31.8K	1.31%	15
2015 Q1	$2.04M	Sell	20,749 -2,200	-10%	-$223K	1.18%	17
2014 Q4	$2.16M	Sell	22,949 -3,047	-12%	-$315K	1.35%	14
2014 Q3	$2.77M	Sell	25,996 -1,910	-7%	-$187K	1.87%	10
2014 Q2	$2.31M	Buy	27,906 +76	+0.3%	+$5.92K	1.32%	14
2014 Q1	$1.97M	Buy	+27,830	New	+$2.18M	1.49%	14

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Confluence Wealth Management's GILD Position: Q4 2018 in Review

Confluence Wealth Management sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 4,142 shares — an estimated $320K sold.

Confluence Wealth Management first reported a position in GILD in Q1 2014 and held it in 14 quarters. The position peaked at $2.77M in Q3 2014. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

Confluence Wealth Management reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
Confluence Wealth Management sold 4,142 Gilead Sciences shares in Q4 2018, an estimated $320K.
Confluence Wealth Management first reported a position in Gilead Sciences in Q1 2014 and held it in 14 quarters.
Confluence Wealth Management's Gilead Sciences position peaked at $2.77M in Q3 2014.
1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Confluence Wealth Management's 13F filing for Q4 2018, filed 12 Feb 2019.